A new intraocular lens (IOL) developed by Bausch & Lomb has been described as ‘a step closer to the holy grail of IOL’s’ by a group of leading ophthalmologists.
Crystalens HD is an accommodating IOL for primary implantation in the capsular bag of the eye for the visual correction of aphakia after the removal of the cataractous lens in adult patients with and without presbyopia. It has been reimbursed via the Prostheses List since last August.
Mr. Nicholas Shorter, Commercial Director, Surgical at Bausch & Lomb, predicts that the Crystalens HD technology will change the way presbyopia and cataracts are treated in Australia.
The Crystalens HD is the only intraocular lens that utilises the natural focussing ability of the eye by using the eye muscle to flex and accommodate in order to focus on objects that are distant, near and everywhere in between.
“Bausch & Lomb has been accrediting surgeons in the use of the new technology for the past several months,” Mr. Shorter says.
Bausch & Lomb officially launched Crystalens HD at the Australasian Society of Cataract and Refractive Surgeons conference in Darwin in July and is currently rolling-out Crystalens HD to the wider ophthalmic community. Surgeons will be instructed and certified in the use of Crystalens HD in their practice.
Dr. Peter Heiner from Vision Eye Institute on the Gold Coast has performed 24 Crystalens HD procedures and has received positive feedback from IOL patients.
“Most patients following this procedure have obtained good distance vision and are glasses free for intermediate vision such as using their computer screen or reading a menu in a restaurant,” Dr. Heiner says.
“Crystalens HD really is a breakthrough in cataract and refractive surgery and we can now restore sight without compromising the intermediate focus that people rely on to watch television, use a computer or interact with other people.”
[/vc_column_text][/vc_column]
